Expert Opinion on Therapeutic Targets

2.2k papers and 71.0k indexed citations i.

About

The 2.2k papers published in Expert Opinion on Therapeutic Targets in the last decades have received a total of 71.0k indexed citations. Papers published in Expert Opinion on Therapeutic Targets usually cover Molecular Biology (1.1k papers), Oncology (479 papers) and Immunology (354 papers) specifically the topics of Cytokine Signaling Pathways and Interactions (88 papers), Peptidase Inhibition and Analysis (77 papers) and Epigenetics and DNA Methylation (74 papers). The most active scholars publishing in Expert Opinion on Therapeutic Targets are Stamatios Theocharis, James A. McCubrey, Dong‐Qing Ye, Hai‐Feng Pan and Anurag Kuhad.

In The Last Decade

Fields of papers published in Expert Opinion on Therapeutic Targets

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Expert Opinion on Therapeutic Targets. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Expert Opinion on Therapeutic Targets

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Expert Opinion on Therapeutic Targets. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Expert Opinion on Therapeutic Targets with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025